The Penta Foundation for the Second Time Awarded the Best Diploma Theses at the Faculty of Pharmaceutics in Brno

11. May 2007
Back

The Penta Foundation and the pharmacy chain Dr. Max jointly awarded the best diploma theses of students of the Faculty of Pharmaceutics of the University of Veterinary and Pharmaceutical Sciences in Brno this year. Each institute of the Faculty, i.e., five institutes selected the most contributive work in the given field. Professors, who participated in this year’s pleas, were deciding on the winning diploma theses. Selected authors received a 10,000 CZK award.

“The objective of this award is to accentuate the students responsibly approaching to their study and whose diploma thesis got ahead of their colleagues’ works,” says Martin Kúšik, chairman of the Managing Board of the Foundation, and adds:”Support of educational system and education is one of key areas of the activities of the Penta Foundation. We have been seeking and supporting the best students from various branches on a long-term basis.”

Review of awarded students for the academic year 2006/2007:

Institute of Applied Pharmacy

Author: Michaela Dvořáková
Title: Discrimination Scheme in Selection of Medicaments Sold over the Counter (Gynecologic and Urologic Difficulties)

Institute of Natural Medicine

Author: Jana Věntusová
Title: Gender Orobanche – Content Substances and Their Biologic Activities

Institute of Technology of Medicaments

Author: Gabriela Škrabáková
Title: Assessment of Features of Pellets Prepared by Extrusion/Spheronization

Institute of Human Pharmacology and Toxicology

Author: Michal Kolorz
Title: Detection of DNA of Polymorphism Delta32 in a Receptor CCR5 by PCR Method

Institute of Chemical Medicaments

Author: Marie Marečková
Title: High-efficiency Column Liquid Chromatography in Evaluation of Quality of Medicaments and Additional Substances

Contact:
Jana Studničková
Nadace Penta
Na Příkopě 15
Prague 1
Tel: 210 083 111

More news
Penta Has Been Developing Healthcare Infrastructure for Decades. A New Fund Now Opens It Up to Investors

Penta Fund is expanding its investment offering with a third fund. The Penta Healthcare Infrastructure Fund will enable investors to participate in the development of healthcare infrastructure through a diversified...

Slovakia returns to the ranks of aluminium producers. Slovalco resumes production

After more than three years, Slovakia is returning to the ranks of countries that produce primary aluminium. Slovalco, a joint venture of Hydro and Penta Investments, has begun the gradual...

Penta Real Estate, J&T and AKIPIA Join Forces to Develop a New €3.7 Billion District in Bubny

Penta Real Estate has acquired a 50% stake in HoldCo Bubny s.r.o., which owns key land plots in the Bubny-Zátory area. Penta Real Estate will become the lead developer of...

Dôvera and Union Health Insurance Companies Join Forces

Achmea B.V., the shareholder of Union, and Dôvera, a member of the Penta investment group, have signed a share purchase agreement under which Union Health Insurance Company will become part...

Penta Hospitals Enters the Estonian Market by Acquiring the Country’s Leading Senior Care Provider

The transaction marks the group’s entry into its fourth EU market and strengthens its position in long-term care, one of the key healthcare and social care challenges across Europe. Penta...

Privatbanka Becomes Penta Bank

Penta Investments is reinforcing its position in the financial services sector, which it sees as an attractive opportunity for further growth. A key milestone in this strategy is the transformation...

Penta Real Estate strengthens its holding structure. David Musil appointed CEO

Penta Real Estate, the real estate division of Penta Investments, is entering a new phase of development. Evolving from a regional developer with a dominant position in the Czech Republic...

Exceptional results reflecting a resilient portflolio

Penta reported a record net profit of €714 million for the financial year 2025, driven by profitable growth in all its key investments.